Top

Published in:

01-02-2020 | Review

Prognostic and clinicopathological significance of long non-coding RNA in glioma

Authors: Junhong Li, Ruofei Liang, Chen Song, Yufan Xiang, Yanhui Liu

Published in: Neurosurgical Review | Issue 1/2020

Abstract

Growing evidence from recent studies have revealed that long non-coding RNA (lncRNA) might be a useful prognostic biomarker for glioma; we therefore conducted the current meta-analysis to evaluate prognostic and clinicopathological predictive value of lncRNA expression for glioma patients. Eligible studies were identified through multiple research strategies in PubMed, EMBASE, Web of Science, and Cochrane Library up to May 2017. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were utilized to calculate patient’s survival. Fourteen eligible studies with 1415 patients were ultimately included in this meta-analysis. Our meta-analysis showed a significant association between high lncRNA expression level and OS in glioma patients (HR 2.09, 95% CI 1.68–2.58, P < 0.001). Subgroup analysis was conducted to explore the potential heterogeneity. As for clinicopathological parameters, lncRNA expression was significantly associated with tumor diameter (< 3 vs ≥ 3 cm, OR 0.39, 95% CI 0.27–0.56, P < 0.001; < 5 vs ≥ 5 cm, OR 0.56, 95% CI 0.34–0.92, P = 0.02), tumor grade (OR 0.21, 95% CI 0.13–0.34, P < 0.001), and Karnofsky Performance Status Scale (OR 2.52, 95% CI 1.54–4.11, P < 0.001). LncRNA may serve as a biomarker for prognosis and clinicopathological features in glioma patients.

Jiang C, Li X, Zhao H, Liu H (2016) Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer 15:62. https://doi.org/10.1186/s12943-016-0545-z CrossRefPubMedPubMedCentral

Reon BJ, Anaya J, Zhang Y, Mandell J (2016) Expression of lncRNAs in low-grade gliomas and glioblastoma multiforme: an in silico analysis. 13:e1002192. https://doi.org/10.1371/journal.pmed.1002192 CrossRef

Li CH, Chen Y (2013) Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol 45:1895–1910. https://doi.org/10.1016/j.biocel.2013.05.030 CrossRefPubMed

Pan Y, Li C, Chen J, Zhang K, Chu X, Wang R, Chen L (2016) The emerging roles of long noncoding RNA ROR (lincRNA-ROR) and its possible mechanisms in human cancers. Cell Physiol Biochem 40:219–229. https://doi.org/10.1159/000452539 CrossRefPubMed

Qin X, Yao J, Geng P, Fu X, Xue J, Zhang Z (2014) LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int J Clin Exp Pathol 7:3065–3072PubMedPubMedCentral

Liu S, Mitra R, Zhao MM, Fan W, Eischen CM, Yin F, Zhao Z (2016) The potential roles of long noncoding RNAs (lncRNA) in glioblastoma development. Mol Cancer Ther 15:2977–2986. https://doi.org/10.1158/1535-7163.MCT-16-0320 CrossRefPubMedPubMedCentral

Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, Qian J, Liu N, You Y (2014) Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One 9:e86295. https://doi.org/10.1371/journal.pone.0086295 CrossRefPubMedPubMedCentral

Yu X, Li Z (2015) Long non-coding RNA HOTAIR: a novel oncogene (review). Mol Med Rep 12:5611–5618. https://doi.org/10.3892/mmr.2015.4161 CrossRefPubMed

Guo H, Hu G, Yang Q, Zhang P, Kuang W, Zhu X, Wu L (2016) Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells. Oncotarget 7:81806–81814. https://doi.org/10.18632/oncotarget.13242 CrossRefPubMedPubMedCentral

10.

Bian EB, Li J, Xie YS, Zong G, Li J, Zhao B (2015) LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs with EZH2. J Cell Physiol 230:496–503. https://doi.org/10.1002/jcp.24549 CrossRefPubMed

11.

Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, Zhang A, Jia Z, Wang G, Yu S, Pu P, Dong L, Kang C (2012) LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 40:2004–2012. https://doi.org/10.3892/ijo.2012.1413 CrossRefPubMed

12.

Meseure D, Alsibai KD, Nicolas A, Bieche I, Morillon A (2015) Long noncoding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets. Biomed Res Int 2015:1–14. https://doi.org/10.1155/2015/320214 CrossRef

13.

Sun Y, Wang Z, Zhou D (2013) Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas. Med Hypotheses 81:319–321. https://doi.org/10.1016/j.mehy.2013.04.010 CrossRefPubMed

14.

Wang L, Yu Z, Sun S, Peng J, Xiao R, Chen S, Zuo X, Cheng Q, Xia Y (2017) Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis. Rev Neurosci 28:375–380. https://doi.org/10.1515/revneuro-2016-0066 CrossRefPubMed

15.

Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834CrossRef

16.

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. https://doi.org/10.1186/1745-6215-8-16 CrossRefPubMedPubMedCentral

17.

Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826CrossRef

18.

Zhao W, Sun C, Cui Z (2017) A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma. Clin Transl Oncol. https://doi.org/10.1007/s12094-016-1597-7 CrossRef

19.

Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin CZ, Qu Q, Wang GH, He CJ, Zhou HH (2016) A long noncoding RNA ZEB1-AS1 promotes tumorigenesis and predicts poor prognosis in glioma. Int J Mol Sci 17. https://doi.org/10.3390/ijms17091431 CrossRef

20.

Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, Pu P, Kang C, Han L (2016) A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett 373:251–259. https://doi.org/10.1016/j.canlet.2016.01.039 CrossRefPubMed

21.

He C, Jiang B, Ma J, Li Q (2016) Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 124:169–174. https://doi.org/10.1111/apm.12480 CrossRefPubMed

22.

Liu C, Sun Y, She X, Tu C, Cheng X, Wang L, Yu Z, Li P, Liu Q, Yang H, Li G, Wu M (2017) CASC2c as an unfavorable prognosis factor interacts with miR-101 to mediate astrocytoma tumorigenesis. Cell Death Dis 8:e2639. https://doi.org/10.1038/cddis.2017.11 CrossRefPubMedPubMedCentral

23.

Chen ZH, Hu HK, Zhang CR, Lu CY, Bao Y, Cai Z, Zou YX, Hu GH, Jiang L (2016) Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells. Am J Transl Res 8:4106–4119PubMedPubMedCentral

24.

Jing SY, Lu YY, Yang JK, Deng WY, Zhou Q, Jiao BH (2016) Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival. Eur Rev Medical Pharmacol Sci 20:3992–3996

25.

Yan H, Tian R, Zhang M, Wu J, Ding M, He J (2017) High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma. OncoTargets Therapy 10:113–120. https://doi.org/10.2147/ott.s124614 CrossRefPubMed

26.

Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, Yu SZ, Pu PY, Liu N, You YP, Jiang T, Kang CS (2013) HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro-Oncology 15:1595–1603. https://doi.org/10.1093/neuonc/not131 CrossRefPubMedPubMedCentral

27.

Zhang T, Wang YR, Zeng F, Cao HY, Zhou HD, Wang YJ (2016) LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675. Eur Rev Medical Pharmacol Sci 20:4891–4897

28.

Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P, Wu JW (2015) Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol 36:3355–3359. https://doi.org/10.1007/s13277-014-2969-7 CrossRefPubMed

29.

Zhuang JJ, Yue M, Zheng YH, Li JP, Dong XY (2016) Long non-coding RNA MVIH acts as a prognostic marker in glioma and its role in cell migration and invasion. Eur Rev Medical Pharmacol Sci 20:4898–4904

30.

Zhou Y, Wang DL, Pang Q (2016) Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma. Eur Rev Med Pharmacol Sci 20:3035–3039. https://doi.org/10.1016/j.canlet.2016.08.009 CrossRefPubMed

31.

Hu L, Lv QL, Chen SH, Sun B, Qu Q, Cheng L, Guo Y, Zhou HH, Fan L (2016) Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma. Int J Environ Res Public Health 13:433. https://doi.org/10.1186/s13041-016-0226-2 10.3390/ijerph13040433CrossRefPubMedPubMedCentral

32.

Ramos AD, Attenello FJ, Lim DA (2016) Uncovering the roles of long noncoding RNAs in neural development and glioma progression. Neurosci Lett 625:70–79. https://doi.org/10.1016/j.neulet.2015.12.025 CrossRefPubMed

33.

Zhang XQ, Leung GK (2014) Long non-coding RNAs in glioma: functional roles and clinical perspectives. Neurochem Int 77:78–85. https://doi.org/10.1016/j.neuint.2014.05.008 CrossRefPubMed

34.

Qureshi IA, Mehler MF (2013) Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics 10:632–646. https://doi.org/10.1007/s13311-013-0199-0 CrossRefPubMedPubMedCentral

35.

Kiang KM, Zhang XQ, Leung GK (2015) Long non-coding RNAs: the key players in glioma pathogenesis. Cancers (Basel) 7:1406–1424. https://doi.org/10.3390/cancers7030843 CrossRef

36.

Hu GW, Wu L, Kuang W, Chen Y, Zhu XG, Guo H, Lang HL (2017) Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway. Gene 610:24–31. https://doi.org/10.1016/j.gene.2017.02.006 CrossRefPubMed

37.

Li J, Wang YM, Song YL (2016) Knockdown of long noncoding RNA AB073614 inhibits glioma cell proliferation and migration via affecting epithelial-mesenchymal transition. Eur Rev Medical Pharmacol Sci 20:3997–4002

38.

Zeng J, Du T, Song Y, Gao Y, Li F, Wu R, Chen Y, Li W, Zhou H, Yang Y, Pei Z (2016) Knockdown of long noncoding RNA CCAT2 inhibits cellular proliferation, invasion, and EMT in glioma cells. Oncol Res 25:913–921. https://doi.org/10.3727/096504016x14792098307036 CrossRefPubMed

39.

Ke J, Yao YL, Zheng J, Wang P, Liu YH, Ma J, Li Z, Liu XB, Li ZQ, Wang ZH, Xue YX (2015) Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. Oncotarget 6:21934–21949. https://doi.org/10.18632/oncotarget.4290 CrossRefPubMedPubMedCentral

40.

Liu H, Lv Z, Guo E (2015) Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol 8:9140–9146PubMedPubMedCentral

41.

Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J, Chen L, Xi Z, Teng H, Wang Z, Li Z, Liu Y (2015) Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett 359:75–86. https://doi.org/10.1016/j.canlet.2014.12.051 CrossRefPubMed

Title: Prognostic and clinicopathological significance of long non-coding RNA in glioma
Authors: Junhong Li
Ruofei Liang
Chen Song
Yufan Xiang
Yanhui Liu
Publication date: 01-02-2020
Publisher: Springer Berlin Heidelberg
Published in: Neurosurgical Review / Issue 1/2020
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-018-0965-x

At a glance: The STEP trials

Springer Medicine

Prognostic and clinicopathological significance of long non-coding RNA in glioma

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

A prediction of postoperative neurological deficits following intracranial aneurysm surgery using somatosensory evoked potential deterioration duration

Inferolateral thalamic ischemia secondary to PCA P2 perforator occlusion mimics MCA stroke syndrome

Teflon™ or Ivalon®: a scoping review of implants used in microvascular decompression for trigeminal neuralgia

Sinking flap syndrome revisited: the who, when and why

RETRACTED ARTICLE: Advantages of clinical pathways in severity-based treatment of spondylodiscitis

Continuous dynamic mapping to avoid accidental injury of the facial nerve during surgery for large vestibular schwannomas